Publication | Open Access

Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study

Breast OncologyEstrogen Receptor BetaMedicineHormonal ReceptorPharmacologyGynecologyHigh-dose EstradiolBreast CancerPhase 2OncologyRadiation OncologyEndocrine-related Cancer